Makker V, Aghajanian C, Cohn AL, Romeo M, et al. A Phase Ib/II Study of Lenvatinib and Pembrolizumab in Advanced Endometrial Carcinoma (Study 111/KEYNOTE-146): Long-Term Efficacy and Safety Update. J Clin Oncol 2023;41:974-979.
PMID: 36608305